

Apple and Amazon Earnings Roll In, Eli Lilly Tanks, And Markets Brace For Jobs Report 5/1/25
5 snips May 1, 2025
Steve Kovac, CNBC's correspondent, and Gene Munster, an analyst from Deepwater Asset Management, delve into the latest earnings reports from heavyweights Apple and Amazon. They discuss Apple's strong performance amidst service challenges and potential tariff impacts. Munster shares insights on Amazon's unexpected cloud growth slowdown, affecting stock reactions. They also touch on Eli Lilly's profit forecast cut and explore market sentiment ahead of a key jobs report, all while naming strategic moves in tech and pharma.
AI Snips
Chapters
Transcript
Episode notes
Tim Cook Sees No iPhone Pull-Forward
- Apple's CEO Tim Cook found no evidence of significant iPhone demand pull-forward before March quarter tariffs.
- This suggests stable underlying demand despite tariff concerns in the March quarter.
Amazon's Optimistic Yet Conservative Guidance
- Amazon's guidance for Q2 appears conservative but strong compared to the street, predicting 2% revenue growth despite challenging retail conditions.
- This implies Amazon sees resilience and possibly a stronger consumer than expected in Q2.
Eli Lilly Faces PBM Setback
- Eli Lilly stock dropped sharply despite earnings beats due to trimmed guidance and CVS Caremark choosing Novo Nordisk's drug as preferred.
- Losing a PBM's preferred status could reduce Lilly's market share but impact is uncertain.